Redesigned lung cancer drug matches tumor control with fewer off-target interactions
Researchers at Moffitt Cancer Center have developed a new chemical approach that could help make targeted cancer medicines safer and more precise. The discovery gives scientists a new way to design drugs that bind more selectively ...
Jul 24, 2026
0
4









